There is no question that NVDA is a killer company with a monster product line. But let's not forget that there is a difference between a good product and a good investment. Valuations matter, and this company is still trading at extreme multiples of the typical metrics - P/E, P/B, P/S.
Even though they've crushed earnings estimates the last two quarters, the stock has responded negatively in both cases, or at least not positively. A failure to react as expected is often a sign of exhaustion and can be seen on the chart with the inability to stay above the $500 level, which may favor a short to medium-term bearish position.
The Bull Case
This is a tricky one though - some analyst estimates put valuations on this bad boy at as high as $1,100/share, which would represent a market capitalization of $2.7 Trillion.
Even with the extremes in the common valuation multiples mentioned above, growth has to be accounted for, and the stock's PEG (Price-to-Earnings-Growth) Ratio is actually at a level that has marked some historical lows in the past.
In the wise words of Elon Musk "Place your bets accordingly".
Informacje i publikacje przygotowane przez TradingView lub jego użytkowników, prezentowane na tej stronie, nie stanowią rekomendacji ani porad handlowych, inwestycyjnych i finansowych i nie powinny być w ten sposób traktowane ani wykorzystywane. Więcej informacji na ten temat znajdziesz w naszym Regulaminie.